Clinical Trials

    Showing 1 - 9 of 9 Transplant Trials

    Status: Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator:

    Phone:

    Kidney transplantation is a good treatment option for people with kidney disease. However, there is still much to learn about how to best care for the transplanted kidney and keep it functioning for a long time. Transplant recipients receive inductio... Read more >

    Status: Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator: Jack Curtis

    Phone: 913.486.9249

    This is a randomized, double-blind, placebo-controlled trial in de novo kidney transplant patients to determine if the addition of fingolimod (brand name Gilenya®, candidate name- FTY720) on the background of standard immunosuppression will prevent e... Read more >

    Status: Enrolling

    Investigator: Howard Huang

    Study Coordinator: Doris Onyekwere

    Phone: 346.238.4586

    The goal of this clinical trial is to compare ARINA-1 plus Standard of Care vs Standard of Care alone. The main question it aims to answer are: Evaluate the effectiveness of ARINA-1 in preventing bronchiolitis obliterans syndrome (BOS) progression... Read more >

    Status: Open Not Enrolling

    Investigator: Nabil Tariq

    Study Coordinator: Nicole Hinton

    Phone: 281.755.0796

    This study is designed to evaluate the post-operative complications and re-herniations following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.... Read more >

    Status: Open Not Enrolling

    Investigator: Ahmed Gaber

    Study Coordinator: Beatriz Efron

    Phone: 713.363.8890

    An open-label, controlled, randomized Phase 3 trial evaluating 12-month kidney function in highly sensitized (cPRA =99.9%) kidney transplant patients with positive crossmatch against a deceased donor, comparing desensitization using imlifidase with s... Read more >

    Status: Open Not Enrolling

    Investigator: Mahwash Kassi

    Study Coordinator: Jan-Michael Ragunton

    Phone: 346.238.0218

    To evaluate the efficacy of eplontersen compared to placebo for 120 weeks in patients with ATTR-CM receiving available standard of care (SoC). For more information, please visit https://www.cardio-ttransform.com.... Read more >

    Status: Open Not Enrolling

    Investigator: Maen Abdelrahim

    Study Coordinator: Elsie Rizk

    Phone: 713.441.2557

    We propose a regimen of six months neoadjuvant lenvatinib in combination with transcatheter arterial chemoembolization (TACE) prior to liver transplantation in patients with hepatocellular carcinoma (HCC) beyond Milan Criteria. Clinical, outcomes, an... Read more >

    Status: Open Not Enrolling

    Investigator: Howard Huang

    Study Coordinator: Nicole Hinton

    Phone: 281.755.0796

    The LAMBDA 002 registry study is an observational, longitudinal, multi-center study observing patients undergoing lung transplant.... Read more >

    Status: Enrolling

    Investigator: Howard Huang

    Study Coordinator: Lindsay Barter

    Phone: 502.417.6664

    The purpose of this project is to build a consortium of lung transplant centers wherein blood samples will be collected to evaluate the humoral and immune response of lung transplant recipients to vaccinations, such as COVID-19 and influenza. The bio... Read more >